Expert Review of Anticancer Therapy, Volume 17, Issue 3 (2017)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Anticancer Therapy, Volume 17, Issue 3 (2017)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Volume 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Minimizing toxicity in breast irradiation
Chirag Shah, Bhanu Banda, Rohit Chandra & Frank Vicini
Pages: 187-189
Published online: 29 Jan 2017
First Page PreviewforMinimizing toxicity in breast irradiation | Full Text | References | PDF (304 KB)
  • 1048 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer
Lindsey E. Minion & Krishnansu S. Tewari
Pages: 191-198
Published online: 15 Feb 2017
AbstractforThe safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer | Full Text | References | PDF (845 KB)
  • 674 Views
  • 16 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
A new frontier for targeted therapy in NSCLC: clinical efficacy of pembrolizumab in the inhibition of programmed cell death 1 (PD-1)
Raffaele Addeo
Pages: 199-201
Published online: 08 Feb 2017
AbstractforA new frontier for targeted therapy in NSCLC: clinical efficacy of pembrolizumab in the inhibition of programmed cell death 1 (PD-1) | Full Text | References | PDF (303.2 KB)
  • 705 Views
  • 8 CrossRef citations
  • 0Altmetric

Review

Review
Non-visible asymptomatic haematuria: a review of the guidelines from the urologist’s perspective
Petros Sountoulides, Ioannis Mykoniatis & Linda Metaxa
Pages: 203-216
Published online: 27 Jan 2017
AbstractforNon-visible asymptomatic haematuria: a review of the guidelines from the urologist’s perspective | Full Text | References | PDF (1 MB)
  • 338 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges
José Luis González-Larriba, Pablo Maroto, Ignacio Durán, Julio Lambea, Luis Flores, Daniel Castellano & the Changing Group
Pages: 217-226
Published online: 20 Jan 2017
AbstractforThe role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges | Full Text | References | PDF (759.3 KB)
  • 409 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma
Sergio Bracarda, Sylvie Negrier, Jochen Casper, Camillo Porta, Manuela Schmidinger, James Larkin, Marine Gross Goupil & Bernard Escudier
Pages: 227-233
Published online: 03 Jan 2017
AbstractforHow clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma | Full Text | References | PDF (563.8 KB)
  • 694 Views
  • 9 CrossRef citations
  • 0Altmetric
Review
Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature
Riccardo Campi, Andrea Minervini, Andrea Mari, Georgios Hatzichristodoulou, Francesco Sessa, Albero Lapini, Maurizio Sessa, Jurgen Erich Gschwend, Sergio Serni, Marco Roscigno & Marco Carini
Pages: 235-246
Published online: 06 Feb 2017
AbstractforAnatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature | Full Text | References | PDF (1.7 MB) | Supplemental
  • 300 Views
  • 9 CrossRef citations
  • 0Altmetric
Review
Chemoprevention of colorectal cancer in inflammatory bowel disease
Adam C. Ehrlich, Shyam Patel, Andrew Meillier, Robin D. Rothstein & Frank K. Friedenberg
Pages: 247-255
Published online: 01 Feb 2017
AbstractforChemoprevention of colorectal cancer in inflammatory bowel disease | Full Text | References | PDF (698.9 KB)
  • 413 Views
  • 12 CrossRef citations
  • 0Altmetric
Review
Newer medical therapies for metastatic soft tissue sarcoma
Akash Tiwari, Vineet Govinda Gupta & Sameer Bakhshi
Pages: 257-270
Published online: 06 Feb 2017
AbstractforNewer medical therapies for metastatic soft tissue sarcoma | Full Text | References | PDF (1,011.8 KB)
  • 333 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow
I. B. Greenwell, C. R. Flowers, K. A. Blum & J. B. Cohen
Pages: 271-279
Published online: 06 Feb 2017
AbstractforClinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow | Full Text | References | PDF (748.5 KB) | Supplemental
  • 811 Views
  • 45 CrossRef citations
  • 0Altmetric

Original Research

Article
Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologists
Yolanda D Tseng, Smith Apisarnthanarax, Jay J Liao, Shailender Bhatia, Paul T Nghiem & Upendra Parvathaneni
Pages: 281-287
Published online: 29 Jan 2017
AbstractforFactors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologists | Full Text | References | PDF (838.3 KB)
  • 153 Views
  • 8 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 23 Jul 2024
Bevacizumab-containing treatment for relapsed or refractory Wilms tumor
Sarah Al-Jilaihawi et al.
Review Article | Published online: 23 Jul 2024
UNDERSTANDING the LINK BETWEEN ASPARTAME and CANCER
Morando Soffritti
Report | Published online: 23 Jul 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancer
Peter D. Zang et al.
Review Article | Published online: 22 Jul 2024
View all latest articles